Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of oral cancer recurrence
ChiCTR1800016985Phase 4Completed
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in mouth cancer and Oral Mucosal Carcinoma (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: blood routine examination, lactic acid and 3 more. Started Oct 2017; status: completed.
02
Drugs
metformin
03
Conditions
mouth cancerOral Mucosal Carcinoma
Beyond the preview
Go deeper on ChiCTR1800016985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016985.